의료용품(ko) › Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or in forms or(en)
其他麻醉剂
HS 300490美国 → 台湾
1概览
- 目的国关税: 0% (第一栏, 30049010107) — 与美国无优惠协定,适用基本/最惠国税率。
- 营业税(相当于增值税): 5%
- 该编码涵盖: 其他麻醉剂
- 需留意的制度: Taiwan express low-value exemption and frequency capExpress consignments up to NT$2,000 are duty free, but a consignee exceeding six such entries in a half-year loses the exemption and moves to formal declaration.web.customs.gov.tw
要点
- 小额免税:同批货物完税价格新台币 2,000 元以下免征关税、营业税与货物税;同一纳税义务人半年度内超过 6 次的列为频繁进口,不再适用。
- 营业税 5%,由海关代征;另有推广贸易服务费 0.04%、货物税(限法定项目)与烟酒税。
- 委托报关业者非强制,纳税义务人可自行报关,但仍须通过关港贸单一窗口以电子方式申报。
- 快件按完税价格分为 X1(文件)、X2(2,000 元以下免税)、X3(2,001 至 50,000 元应税)、X4(超过 50,000 元,须以一般进口报单申报)。
- 自中国大陆进口前,务必查询货品分类表「输入规定」栏是否列有 MW0 或 MP1。
数据日期: 2026-07-29
2归类
HS6 品名
- ko기타
- enOther anesthetics
- zh_hant其他麻醉劑
- zh_hans其他麻醉剂
台湾 税则子目
| 子目 | 品名 |
|---|---|
| 30049010107 | 醫藥製劑,含有硫美妥者(包括異構物、酯類、醚類及鹽類)Medicaments,containing thiamylal,5-allyl-5-(1-methylbutyl)-2-thiobarbiturates, including: Isomers, Esters, Ethers, Salts |
| 30049010205 | 醫藥製劑,含有愷他命及其異構物、酯類、醚類及鹽類者Medicaments, containing Ketamine , and its isomer, esters, ethers, salts |
| 30049010303 | 醫藥製劑,含有丙泊酚、依托咪酯,及其異構物、酯類、醚類及鹽類者Medicaments, containing Propofol , Etomidate, and their isomer, esters, ethers, salts |
| 30049010900 | 其他麻醉劑Other anesthetics |
| 30049020007 | 血液代用品與血漿代用品及基因重組製劑Substitutes of blood, substitutes of plasma and preparations of gennetic recombinants |
| 30049030005 | 營養與電解質液Nutrients and electrolytes |
| 30049040003 | 洗腎用清洗液,具有劑量或零售包裝式樣者Hemodialysis concentrate, put up in measured doses or in forms or packings for retail sale |
| 30049050000 | 磺胺藥Antibacterial, sulfa drugs |
| 30049061007 | 中藥酒劑Chinese medicine wine |
| 30049069009 | 其他中藥製劑Other chinese medicine preparations |
| 30049071005 | 抗癌藥Anti-cancer preparations |
| 30049072004 | 抗人類免疫缺乏病毒感染用藥Drugs for anti human immunodeficiency virus (HIV) infections |
| 30049080004 | 農藥中毒解毒劑Pesticide-poisoning cures |
| 30049091001 | 抗排斥醫藥製劑Immunosuppressive preparations |
| 30049092000 | 安瓿裝蒸餾水Water, distilled, in ampoules |
| 30049099101 | 抗過敏抗組織胺用藥Drugs for antihypersensitivity and antihistamine |
| 30049099218 | 醫藥製劑,含有西可巴比妥者Medicaments, containing secobarbital |
| 30049099227 | 醫藥製劑,含有異戊巴比妥者Medicaments, containing amobarbital |
| 30049099316 | 醫藥製劑,含有三唑他(三唑侖)者Medicaments, containing Triazolam |
| 30049099325 | 醫藥製劑,含有氟硝西泮者Medicaments, containing Flunitrazepam |
| 30049099334 | 醫藥製劑,含有氯甲西泮(甲基樂耐平)者Medicaments, containing Lormetazepam |
| 30049099343 | 醫藥製劑,含有氟地西泮(氟二氮平)者Medicaments, containing Fludiazepam |
| 30049099352 | 醫藥製劑,含有舒樂安定(伊疊唑侖)者Medicaments, containing Estazolam |
| 30049099361 | 醫藥製劑,含有阿普唑他(三氮二氮平)者Medicaments, containing Alprazolam |
| 30049099370 | 醫藥製劑,含有替馬西泮(甲羥氮平)者Medicaments, containing Temazepam |
| 30049099389 | 醫藥製劑,含有咪達唑他(咪氟唑侖)者Medicaments, containing Midazolam |
| 30049099414 | 醫藥製劑,含有特拉嗎竇者Medicaments, containing Tramadol |
| 30049099423 | 醫藥製劑,含有伯替唑他者Medicaments, containing Brotizolam |
| 30049099432 | 醫藥製劑,含有唑匹可隆者Medicaments, containing Zopiclone |
| 30049099441 | 玻璃體替代物Viscoelastic material for ophthalmic surgery |
| 30049099450 | 醫藥製劑,含有札來普隆者Medicaments, containing Zaleplon |
| 30049099469 | 醫藥製劑,含有佐沛眠者Medicaments, containing Zolpidem |
| 30049099520 | 醫藥製劑,含有瑞吩坦尼及其異構物、酯類、醚類及鹽類者Medicaments, containing Remifentanil, and its isomer, esters, ethers, salts |
| 30049099539 | 醫藥製劑,含有阿華吩坦尼及其異構物、酯類、醚類及鹽類者Medicaments, containing Alfentanyl , and its isomer, esters, ethers, salts |
| 30049099548 | 醫藥製劑,含有吩坦尼及其異構物、酯類、醚類及鹽類者Medicaments, containing Fentanyl , and its isomer, esters, ethers, salts |
| 30049099557 | 醫藥製劑,含有美沙冬及其異構物、酯類、醚類及鹽類者Medicaments, containing Methadone , and its isomer, esters, ethers, salts |
| 30049099566 | 醫藥製劑,含有潘他唑新及其異構物、酯類、醚類及鹽類者Medicaments, containing Pentazocine , and its isomer, esters, ethers, salts |
| 30049099575 | 醫藥製劑,含有蘇吩坦尼及其異構物、酯類、醚類及鹽類者Medicaments, containing Sufentanil , and its isomer, esters, ethers, salts |
| 30049099584 | 醫藥製劑,含有四氫大麻酚及其異構物、酯類、醚類及鹽類者Medicaments, containing Tetrahydrocannabinols, and its isomer, esters, ethers, salts |
| 30049099593 | 醫藥製劑,含有派醋甲酯及其異構物、酯類、醚類及鹽類者Medicaments, containing Methylphenidate , and its isomer, esters, ethers, salts |
| 30049099619 | 醫藥製劑,含有他噴他竇及其異構物、酯類、醚類及鹽類者Medicaments, containing Tapentadol, and its isomers, esters, ethers, salts |
| 30049099628 | 醫藥製劑,含有戊巴比妥(不含異戊巴比妥)及其異構物、酯類、醚類及鹽類者Medicaments, containing Pentobarbital(excluding amobarbital), and its isomer, esters, ethers, salts |
| 30049099637 | 醫藥製劑,含有硝甲西泮(硝甲氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Nimetazepam , and its isomer, esters, ethers, salts |
| 30049099646 | 醫藥製劑,含有巴比妥及其異構物、酯類、醚類及鹽類者Medicaments, containing Barbital , and its isomer, esters, ethers, salts |
| 30049099655 | 醫藥製劑,含有溴西泮(溴氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Bromazepam , and its isomer, esters, ethers, salts |
| 30049099664 | 醫藥製劑,含有勞拉西泮(樂耐平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Lorazepam , and its isomer, esters, ethers, salts |
| 30049099673 | 醫藥製劑,含有美達西泮(美達氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Medazepam , and its isomer, esters, ethers, salts |
| 30049099682 | 醫藥製劑,含有甲丙氨酯(美普巴邁)及其異構物、酯類、醚類及鹽類者Medicaments, containing Meprobamate , and its isomer, esters, ethers, salts |
| 30049099691 | 醫藥製劑,含有硝西泮(耐妥眠)及其異構物、酯類、醚類及鹽類者Medicaments, containing Nitrazepam , and its isomer, esters, ethers, salts |
| 30049099717 | 醫藥製劑,含有去甲西泮(原氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Nordazepam , and its isomer, esters, ethers, salts |
| 30049099726 | 醫藥製劑,含有去甲羥安定(歐沙氮平、去甲羥氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Oxazepam , and its isomer, esters, ethers, salts |
| 30049099735 | 醫藥製劑,含有噁唑他(㗁甲唑侖)及其異構物、酯類、醚類及鹽類者Medicaments, containing Oxazolam , and its isomer, esters, ethers, salts |
| 30049099744 | 醫藥製劑,含有匹嗎啉(苯㗁唑啉)及其異構物、酯類、醚類及鹽類者Medicaments, containing Pemoline , and its isomer, esters, ethers, salts |
| 30049099753 | 醫藥製劑,含有氯巴占(甲酮氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing clobazam , and its isomer, esters, ethers, salts |
| 30049099762 | 醫藥製劑,含有氯硝西泮(可那氮平、氯硝氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Clonazepam , and its isomer, esters, ethers, salts |
| 30049099771 | 醫藥製劑,含有氯拉䓬酸(氯氮平酸鹽)及其異構物、酯類、醚類及鹽類者Medicaments, containing Clorazepate , and its isomer, esters, ethers, salts |
| 30049099780 | 醫藥製劑,含有氯噁唑他(氯㗁唑侖)及其異構物、酯類、醚類及鹽類者Medicaments, containing Cloxazolam , and its isomer, esters, ethers, salts |
| 30049099799 | 醫藥製劑,含有安定(二氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Diazepam , and its isomer, esters, ethers, salts |
| 30049099815 | 醫藥製劑,含有氟安定(氟路洛)及其異構物、酯類、醚類及鹽類者Medicaments, containing Flurazepam , and its isomer, esters, ethers, salts |
| 30049099824 | 醫藥製劑,含有普拉西泮(環丙氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Prazepam , and its isomer, esters, ethers, salts |
| 30049099833 | 醫藥製劑,含有莫待芬寧及其異構物、酯類、醚類及鹽類者Medicaments, containing Modafinil , and its isomer, esters, ethers, salts |
| 30049099842 | 醫藥製劑,含有美妥芬諾及其異構物、酯類、醚類及鹽類者Medicaments, containing Butorphanol , and its isomer, esters, ethers, salts |
| 30049099851 | 醫藥製劑,含有氯苄雷司及其異構物、酯類、醚類及鹽類者Medicaments, containing Clobenzorex , and its isomer, esters, ethers, salts |
| 30049099860 | 醫藥製劑,含有離胺右旋安非他命及其異構物、酯類、醚類及鹽類者Medicaments, containing Lisdexamphetamine , and its isomer, esters, ethers, salts |
| 30049099904 | 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale |
美国 出口侧编码(参考)
- 3004.90.10.00Containing antigens or hyaluronic acid or its sodium salt
- 3004.90.92Other
- 3004.90.92.01For veterinary use
- 3004.90.92.03Containing acyclovir or its salts
- 3004.90.92.04Containing oseltamivir or its salts
- 3004.90.92.05Containing valganciclovir, peramivir or their salts
- 3004.90.92.06Other
- 3004.90.92.07Containing fluconazole or its salts
- 3004.90.92.08Other
- 3004.90.92.09Containing metronidazole or its salts
- 3004.90.92.10Other
- 3004.90.92.11Containing trimethoprim and sulfamethoxazole or their salts
- 3004.90.92.12Other
- 3004.90.92.13Containing levofloxacin or its salts
- 3004.90.92.14Containing linezolid or its salts
- 3004.90.92.15Other
- 3004.90.92.16Containing hydroxyurea or cyclophosphamide or their salts
- 3004.90.92.17Containing tacrolimus or mycophenolate mofetil or its salts
- 3004.90.92.18Other
- 3004.90.92.19Containing metoprolol or its salts
- 3004.90.92.20Containing amiodarone or its salts
- 3004.90.92.21Containing diltiazem or its salts
- 3004.90.92.22Containing hydralazine or its salts
- 3004.90.92.23Containing enoxaparin or its salts
- 3004.90.92.24Containing labetalol or its salts
- 3004.90.92.25Containing argatroban, adenosine, amlodipine, esmolol, dobutamine, phenoxybenzamine or their salts
- 3004.90.92.26Other
- 3004.90.92.27Tolmetin
- 3004.90.92.28Tolmetin sodium dihydrate
- 3004.90.92.29Tolmetin sodium (anhydrous)
- 3004.90.92.30For oral suspension
- 3004.90.92.31Other
- 3004.90.92.32For oral suspension
- 3004.90.92.33Other
- 3004.90.92.34Containing O-Acetylsalicylic acid (Aspirin)
- 3004.90.92.35Containing tramadol
- 3004.90.92.36Other
- 3004.90.92.37Containing dexmedetomidine, etomidate, midazolam, propofol or their salts
- 3004.90.92.38Containing midazolam or its salts
- 3004.90.92.39Containing phenytoin or its salts
- 3004.90.92.40Containing propofol or its salts
- 3004.90.92.41Containing levetiracetam, phenytoin or their salts
- 3004.90.92.42Containing etomidate or its salts
- 3004.90.92.43Other
- 3004.90.92.44Containing lorazepam or its salts
- 3004.90.92.45Containing olanzapine or its salts
- 3004.90.92.46Other
- 3004.90.92.47Containing rocuronium or its salts
- 3004.90.92.48Containing succinylcholine or its salts
- 3004.90.92.49Other
- 3004.90.92.50Containing lidocaine or its salts
- 3004.90.92.51Other
- 3004.90.92.52Laxatives
- 3004.90.92.53Antacids
- 3004.90.92.54Containing famotidine or its salts
- 3004.90.92.55Containing pantoprazole or its salts
- 3004.90.92.56Containing ondansetron or its salts
- 3004.90.92.57Containing glycopyrrolate or its salts
- 3004.90.92.58Containing loperamide or its salts
- 3004.90.92.60Other
- 3004.90.92.61Containing furosemide and its salts
- 3004.90.92.62Containing hydrochlorothiazide or its salts
- 3004.90.92.63Other
- 3004.90.92.64Containing calcium gluconate
- 3004.90.92.65Containing potassium chloride
- 3004.90.92.66Containing sodium bicarbonate, in injection form
- 3004.90.92.67Other
- 3004.90.92.68Cough and cold preparations
- 3004.90.92.69Containing diphenhydramine or its salts
- 3004.90.92.70Other
- 3004.90.92.71Containing albuterol sulfate
- 3004.90.92.72Containing timolol maleate
- 3004.90.92.73Other
- 3004.90.92.74Containing heparin sodium or its salts
- 3004.90.92.75Containing zoledronic acid or its salts
- 3004.90.92.76Other
台湾 案例前三条
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者恢甲清覆甲液-全日型加強配方(未滅菌) EXCILOR FORTE-nail solution(non-sterile)
- 其他中藥製劑枳椇人參茶(Gan-Pyun-Han-Nal) / 液體茶 / 100ML /瓶
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者Hiruscar Silicone Pro(non-sterile) 喜療疤 疤痕護理矽凝膠(未滅菌)
数据日期: 2026-07-29
3关税与税费
与美国无优惠协定,适用基本/最惠国税率。
| 子目 | 品名 | 第一栏 | 第二栏 | 第三栏 |
|---|---|---|---|---|
| 30049010107 | 醫藥製劑,含有硫美妥者(包括異構物、酯類、醚類及鹽類) | 0% | 0% | 0% |
| 30049010205 | 醫藥製劑,含有愷他命及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 0% |
| 30049010303 | 醫藥製劑,含有丙泊酚、依托咪酯,及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 0% |
| 30049010900 | 其他麻醉劑 | 0% | 0% | 0% |
| 30049020007 | 血液代用品與血漿代用品及基因重組製劑 | 0% | 0% | 0% |
| 30049030005 | 營養與電解質液 | 0% | 0% | 10% |
| 30049040003 | 洗腎用清洗液,具有劑量或零售包裝式樣者 | 0% | 0% | 10% |
| 30049050000 | 磺胺藥 | 0% | 0% | 20% |
| 30049061007 | 中藥酒劑 | 20% | 0% | 50% |
| 30049069009 | 其他中藥製劑 | 0% | 0% | 12.5% |
| 30049071005 | 抗癌藥 | 0% | 0% | 0% |
| 30049072004 | 抗人類免疫缺乏病毒感染用藥 | 0% | 0% | 10% |
| 30049080004 | 農藥中毒解毒劑 | 0% | 0% | 0% |
| 30049091001 | 抗排斥醫藥製劑 | 0% | 0% | 10% |
| 30049092000 | 安瓿裝蒸餾水 | 0% | 0% | 10% |
| 30049099101 | 抗過敏抗組織胺用藥 | 0% | 0% | 10% |
| 30049099218 | 醫藥製劑,含有西可巴比妥者 | 0% | 0% | 10% |
| 30049099227 | 醫藥製劑,含有異戊巴比妥者 | 0% | 0% | 10% |
| 30049099316 | 醫藥製劑,含有三唑他(三唑侖)者 | 0% | 0% | 10% |
| 30049099325 | 醫藥製劑,含有氟硝西泮者 | 0% | 0% | 10% |
| 30049099334 | 醫藥製劑,含有氯甲西泮(甲基樂耐平)者 | 0% | 0% | 10% |
| 30049099343 | 醫藥製劑,含有氟地西泮(氟二氮平)者 | 0% | 0% | 10% |
| 30049099352 | 醫藥製劑,含有舒樂安定(伊疊唑侖)者 | 0% | 0% | 10% |
| 30049099361 | 醫藥製劑,含有阿普唑他(三氮二氮平)者 | 0% | 0% | 10% |
| 30049099370 | 醫藥製劑,含有替馬西泮(甲羥氮平)者 | 0% | 0% | 10% |
| 30049099389 | 醫藥製劑,含有咪達唑他(咪氟唑侖)者 | 0% | 0% | 10% |
| 30049099414 | 醫藥製劑,含有特拉嗎竇者 | 0% | 0% | 10% |
| 30049099423 | 醫藥製劑,含有伯替唑他者 | 0% | 0% | 10% |
| 30049099432 | 醫藥製劑,含有唑匹可隆者 | 0% | 0% | 10% |
| 30049099441 | 玻璃體替代物 | 0% | 0% | 10% |
| 30049099450 | 醫藥製劑,含有札來普隆者 | 0% | 0% | 10% |
| 30049099469 | 醫藥製劑,含有佐沛眠者 | 0% | 0% | 10% |
| 30049099520 | 醫藥製劑,含有瑞吩坦尼及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099539 | 醫藥製劑,含有阿華吩坦尼及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099548 | 醫藥製劑,含有吩坦尼及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099557 | 醫藥製劑,含有美沙冬及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099566 | 醫藥製劑,含有潘他唑新及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099575 | 醫藥製劑,含有蘇吩坦尼及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099584 | 醫藥製劑,含有四氫大麻酚及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099593 | 醫藥製劑,含有派醋甲酯及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099619 | 醫藥製劑,含有他噴他竇及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099628 | 醫藥製劑,含有戊巴比妥(不含異戊巴比妥)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099637 | 醫藥製劑,含有硝甲西泮(硝甲氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099646 | 醫藥製劑,含有巴比妥及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099655 | 醫藥製劑,含有溴西泮(溴氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099664 | 醫藥製劑,含有勞拉西泮(樂耐平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099673 | 醫藥製劑,含有美達西泮(美達氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099682 | 醫藥製劑,含有甲丙氨酯(美普巴邁)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099691 | 醫藥製劑,含有硝西泮(耐妥眠)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099717 | 醫藥製劑,含有去甲西泮(原氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099726 | 醫藥製劑,含有去甲羥安定(歐沙氮平、去甲羥氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099735 | 醫藥製劑,含有噁唑他(㗁甲唑侖)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099744 | 醫藥製劑,含有匹嗎啉(苯㗁唑啉)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099753 | 醫藥製劑,含有氯巴占(甲酮氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099762 | 醫藥製劑,含有氯硝西泮(可那氮平、氯硝氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099771 | 醫藥製劑,含有氯拉䓬酸(氯氮平酸鹽)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099780 | 醫藥製劑,含有氯噁唑他(氯㗁唑侖)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099799 | 醫藥製劑,含有安定(二氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099815 | 醫藥製劑,含有氟安定(氟路洛)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099824 | 醫藥製劑,含有普拉西泮(環丙氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099833 | 醫藥製劑,含有莫待芬寧及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099842 | 醫藥製劑,含有美妥芬諾及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099851 | 醫藥製劑,含有氯苄雷司及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099860 | 醫藥製劑,含有離胺右旋安非他命及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099904 | 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者 | 0% | 0% | 10% |
- · 营业税=(完税价格+进口税+货物税或烟酒税+烟品健康福利捐)× 5%,依营业税法第 41 条由海关代征。
- · 推广贸易服务费:按完税价格 0.04% 计收(设有最低门槛)。
- · 货物税:仅对货物税条例所列项目征收,例如电器、车辆、油气、水泥、饮料、平板玻璃与橡胶轮胎;计税基础为完税价格加进口税。
- · 烟酒税:卷烟每千支新台币 1,590 元、啤酒每升 26 元、蒸馏酒每升每度 2.5 元等;烟品另加健康福利捐每千支 1,000 元。
- · 特种货物及劳务税:对超过一定金额的小客车、飞机、游艇及高价货物征收 10%。
税费概算
- 采用税率
- 0%
- 完税价格
- —
- 关税
- —
- 营业税(相当于增值税)
- —
- 预估合计
- —
此为概算。实际金额取决于完税价格审定、归类与原产地认定。
数据日期: 2026-07-29
4监管要求
- 503進口人用藥品(包括製劑、原料藥、助診藥類及人用生物製劑):應檢附(一)藥商許可執照影本及衛生福利部核發之(輸入)藥品許可證影本,或(二)衛生福利部核發之同意文件。
Importation of drugs (including pharmaceutical products, active pharmaceutical ingredients, diagnostics and biological products) for human use requires either of the following: (1) a photocopy of the drug (import) license issued by the Ministry of Health and Welfare together with a photocopy of the license of the pharmaceutical firm; or (2) an approval issued by the Ministry of Health and Welfa…
- 504一、進口人用醫療器材應依下列規定辦理:(一)應檢附衛生福利部核發之醫療器材許可證影本或同意文件,並應申報填列醫療器材許可證號碼(十四碼)。(二)如屬危險性醫療儀器,除應檢附衛生福利部核發之醫療器材許可證影本,及申報填列醫療器材許可證號碼(十四碼)外,並須檢附衛生福利部核准醫療機構購置之同意文件。二、非供人用者免依上述規定辦理。
1. Importation of medical devices for human use must be handled according to the following regulations: (1) A photocopy of the medical devices pre-marketing license or an approval document issued by the Ministry of Health and Welfare should be submitted. In addition, the number of the pre-marketing license (consisting of 14 letters and digits) must be declared and listed in the import declaration…
- 505進口中藥藥品(藥品許可證處方內容以中文標示者)應檢附(一)藥商許可執照影本及衛生福利部核發之(輸入)藥品許可證影本,或(二)衛生福利部中醫藥司核發之同意文件。
Importation of Chinese medicines (with the content of the formula of the drug written in Chinese on the import license) requires either of the following: (1) a photocopy of the drug (import) license issued by the Ministry of Health and Welfare together with a photocopy of the license of the pharmaceutical firm; or (2) an approval issued by the Department of Chinese Medicine and Pharmacy, Ministry…
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.
- 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.
- 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.
- 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.
- 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.
- 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.
- 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.
- 804(一)進口人用藥品,應依503規定辦理(二)進口人用醫療器材,應依504規定辦理。(三)進口動物用藥品,應依406規定辦理。(四)進口非屬上述項目者,應註明「本貨品非屬人用藥品、人用醫療器材、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of medical devices for human use is governed by the regulation of"504" (3)Importation of veterinary medicines is governed by the regulation of "406".(4)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is…
- 804(一)進口人用藥品,應依503規定辦理(二)進口人用醫療器材,應依504規定辦理。(三)進口動物用藥品,應依406規定辦理。(四)進口非屬上述項目者,應註明「本貨品非屬人用藥品、人用醫療器材、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of medical devices for human use is governed by the regulation of"504" (3)Importation of veterinary medicines is governed by the regulation of "406".(4)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is…
- 804(一)進口人用藥品,應依503規定辦理(二)進口人用醫療器材,應依504規定辦理。(三)進口動物用藥品,應依406規定辦理。(四)進口非屬上述項目者,應註明「本貨品非屬人用藥品、人用醫療器材、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of medical devices for human use is governed by the regulation of"504" (3)Importation of veterinary medicines is governed by the regulation of "406".(4)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is…
- 814(一)進口人用中藥藥品,應依505規定辦理。(二)進口動物用中藥藥品,應依406規定辦理。(三)進口本項貨品未取得上開主管機關輸入許可文件者,不准進口。
(1) Importation of traditional chinese drugs for human use is governed by the regulation of "505". (2) Importation of veterinary chinese medicines is governed by the regulation of "406".(3) For importing good under this item without import approval document from the competent authority, is not allowed to be imported.
- MP1(一)大陸物品有條件准許輸入,應符合「大陸物品有條件准許輸入項目、輸入管理法規彙總表」之規定。(二)「大陸物品有條件准許輸入項目、輸入管理法規彙總表」內列有特別規定「MXX」代號者,應向國際貿易署辦理輸入許可證;未列有特別規定「MXX」代號者,依一般簽證規定辦理。
(1) Importation of Mainland China products in this category is conditionally permitted. The importation should conform to the regulations of "Consolidated List of Conditional Import Items of Mainland China Origin and Regulations Governing Import of Mainland China Origin Commodities".(2) Importation of items on the "Consolidated List of Conditional Import Items of Mainland China Origin and Regulat…
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
相关机关
- 财政部关务署进口通关、税则归类、关税审定与代征营业税、货物税web.customs.gov.tw
- 关港贸单一窗口进出口报单、输入规定查询与税费缴纳的电子平台portal.sw.nat.gov.tw
- 国际贸易署货品进出口规定、输入许可证、大陆货物输入管理(MW0/MP1)trade.gov.tw
- 标准检验局(BSMI)应施检验商品的报验、验证与商品安全标示bsmi.gov.tw
- 食品药物管理署(TFDA)输入食品边境查验、化妆品产品登录与产品信息档案fda.gov.tw
- 动植物防疫检疫署动植物及其产品的输入检疫aphia.gov.tw
数据日期: 2026-08-27
5单证
美国 出口单证
- 商业发票
- 签发:
- 出口商
- 时点:
- 随货附送
载明买卖双方、品名、数量、价值、币种、贸易条件与原产地;进口国海关同样会查看该单证。
官方页面 - 装箱单
- 签发:
- 出口商
- 时点:
- 随货附送
逐箱内容、重量、体积与唛头。
官方页面 - 提单(B/L)或空运单(AWB)
- 签发:
- 承运人或货运代理
- 时点:
- 装运时签发
运输合同凭证;海运提单同时具有物权凭证性质。
官方页面 - 电子出口信息(EEI)与 ITN
- 签发:
- 出口商或受权代理人,在 ACE 内 AESDirect 申报
- 时点:
- 装载前,按运输方式的期限
当单一 Schedule B 或 HTS 项超过 2,500 美元或需要许可时应申报,ITN 为申报凭证。
官方页面 - 托运人指示书(SLI)
- 签发:
- 出口商
- 时点:
- 由货运代理代为申报时
授权货运代理为代理人,并提供 AES 申报所需数据。
官方页面 - 出口许可证
- 签发:
- 工业安全局(BIS,EAR)或国防贸易管制局(DDTC,ITAR)
- 时点:
- ECCN 或 USML 类别与目的地要求时,于出口前取得
部分情形可适用许可例外;许可证号或例外条款须填入 AES 申报。
官方页面 - 自由贸易协定原产地声明
- 签发:
- 出口商或生产商
- 时点:
- 提供买方用于其进口优惠申报
美韩 FTA 采自我证明、无固定格式。台湾地区与中国大陆无适用协定。
官方页面 - 自由销售证明(CFS)或 FDA 出口证书
- 签发:
- 美国食品药品监督管理局(FDA)或州政府机构
- 时点:
- 进口国主管机构要求时
发往韩国、台湾地区或中国大陆的食品、膳食补充剂、化妆品、药品与医疗器械常被要求。
官方页面 - 委托货运代理的授权书
- 签发:
- 出口商
- 时点:
- 货运代理开始作业前
货运代理据此以受权代理人身份申报 EEI 并对 CBP 办理相关事务。
官方页面
台湾 进口单证
- 进口报单
- 签发:
- 报关业者或进口人,经关港贸单一窗口传输
- 时点:
- 自运输工具进口日的次日起 15 日内
低价快件可改以简易申报单(X1 至 X3)申报;涉及输入规定、退税、配额、特别关税或特种货物税的,须以一般进口报单申报。
官方页面 - 小提单(提货单,D/O)
- 签发:
- 承运人或货运代理
- 时点:
- 货物抵达后换领
凭以从集装箱集散站或仓库提取货物。
官方页面 - 商业发票
- 签发:
- 出口人
- 时点:
- 报关时
审定完税价格的主要依据,应载明品名、数量、单价、贸易条件与原产地。
官方页面 - 装箱单
- 签发:
- 出口人
- 时点:
- 报关时
查验(C3)时作为核对资料。
官方页面 - 提单(B/L)或空运单(AWB)
- 签发:
- 承运人
- 时点:
- 装运时签发
与舱单核对,并作为换领小提单的依据。
官方页面 - 产地证明书
- 签发:
- 出口地签发机构
- 时点:
- 适用优惠税率或输入规定要求时
自中国大陆输入早收清单货品并拟适用 ECFA 优惠的,须附 ECFA 原产地证明书。
官方页面 - 输入许可证
- 签发:
- 国际贸易署或其他主管机关
- 时点:
- 货品分类表「输入规定」栏有相应代号时
无代号的多为免证进口;MW0、MP1 等代号涉及大陆货物的输入管理。
官方页面 - 委任书
- 签发:
- 进口人(纳税义务人)
- 时点:
- 委托报关业者前
报关业者据以代办报关、缴税与提货。
官方页面 - 检验与查验文件
- 签发:
- 标准检验局(BSMI)、食品药物管理署(TFDA)
- 时点:
- 报关同时或报关前
应施检验商品的报验合格证明;输入食品的查验申请;化妆品的产品登录与产品信息档案(PIF)。
官方页面
6流程
- 预报货物信息与进仓承运人传输舱单,货物卸船后进入集装箱集散站、码头或保税仓库。
- 换领小提单与备齐单证向承运人或货运代理换领小提单,备齐发票、装箱单、产地证明与必要的输入许可证。
- 报送进口报单由报关业者或进口人经关港贸单一窗口报送进口报单,申报期限为自运输工具进口日的次日起 15 日内。
- 通关方式筛选系统筛选为 C1(免审免验)、C2(单证审核)或 C3(货物查验,分人工查验 C3M 与机检 C3X)。属应施检验或查验商品的,须先取得主管机关结果。
- 缴纳税费缴纳关税、营业税、货物税(如有)与推广贸易服务费,可在线缴纳,也可按规定申请先放后税。
- 放行与提货取得放行通知后从集散站提货。事后仍有更正、退税与海关事后稽核等程序。
- 舱单与进仓航空公司传输舱单,货物进入航空货运集散站。
- 备齐单证与报送报单备齐单证后经关港贸单一窗口报送进口报单,同样适用 15 日申报期限。
- 通关方式与查验按 C1/C2/C3 分流;属 BSMI 或 TFDA 管理商品的,须完成报验或查验程序。
- 缴税缴纳关税、营业税与相关规费。
- 放行提货从航空货运集散站提取货物。
- 快件分类按完税价格分为 X1(进口快递文件)、X2(2,000 元以下低价免税)、X3(2,001 至 50,000 元低价应税)与 X4(超过 50,000 元高价货物)。
- 简易申报或一般报单X1 至 X3 可用简易申报单申报;X4 及涉及输入规定、退税、配额、特别关税或特种货物税的,须以一般进口报单申报。
- 免税与频繁进口判断完税价格 2,000 元以下的免税,但同一纳税义务人半年度内超过 6 次的列为频繁进口,此后不再适用免税。烟、酒与关税配额农产品不适用。
- 缴税应税的由快递企业代为缴纳后向收货人收取,或由收货人自行缴纳。
- 应施检验商品跨境网购的电器等应施检验商品,仍须按规定报验或申请免验,不符合规定的不予放行并可能受罚。
- 入境申报旅客携带应税或应申报物品入境的,走红色通道并填写申报单。
- 免税额度成年旅客自用行李物品完税价格合计在新台币 20,000 元以下的免税,酒类与烟品另有数量限制。
- 商业性货物非自用的商业性货物即使随身携带,仍须按一般进口程序报关,并符合输入规定与检验要求。
- 缴税超出免税额度的部分在入境时由海关审定价格并当场缴纳。
显示 美国 出口侧流程
- 归类与名单筛查确定 Schedule B 编码,核查该物项是否列入商业管制清单(ECCN)或属 USML,并以 OFAC 与 BIS 名单筛查买方、最终用户与最终用途。
- 订舱与备齐单证向承运人或货运代理订舱,备齐商业发票、装箱单与托运人指示书,并取得适用的出口许可证。
- 申报 EEI在货物装船前至少 24 小时通过 AESDirect 申报 EEI,并记录系统返回的 ITN。
- 进场与装船将货物送交码头。承运人在出口舱单中引用 ITN;未取得 ITN 不应装船。
- 离港与寄送单证开航后取得提单,并将装运单证与原产地声明寄交买方,供其办理进口通关。
- 记录保存出口记录一般自出口日起保存五年;装运内容变更时应更正 AES 申报。
7难度
分数: 0.87
这是依公开数据计算的信号,并非咨询意见。
判定理由
- regime[TFDA] Medicines need a pharmaceutical-firm licence and a per-product marketing licence; even personal-use import is quantity-capped.(en)fda.gov.tw2026-09-07
- requirement6 destination import requirement(s) found: For importation of controlled drugs (including narcotics dru, (1) Importation of medicines for human use is governed by th, Importation of Chinese medicines (with the content of the fo(en)portal.sw.nat.gov.tw2026-09-07
- ambiguityClassification is contested — rulings for this HS6 scatter across several subheadings and are often decided against neighbouring codes(en)web.customs.gov.tw2026-09-07
组成
| 进口要求 | 0.89 | For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an ap portal.sw.nat.gov.tw(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of co portal.sw.nat.gov.twImportation of Chinese medicines (with the content of the formula of the drug written in Chinese on the import license) requires either of the following: (1) a photocopy of the dru portal.sw.nat.gov.tw |
|---|---|---|
| 归类模糊度 | 0.56 | TW 결정례 17건 · 하위 세번 2종으로 분산 web.customs.gov.twUS CROSS 1057건 중 복수 세번 결정 비율 21% · 같은 사건에서 함께 검토된 다른 HS6 66개 rulings.cbp.gov |
| 管制制度 | 1.00 | 藥事法 — 藥商許可執照 + 藥品許可證 fda.gov.tw |
数据日期: 2026-09-07
8案例
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者恢甲清覆甲液-全日型加強配方(未滅菌) EXCILOR FORTE-nail solution(non-sterile)核定编码: 30049099904日期: 2021
- 其他中藥製劑枳椇人參茶(Gan-Pyun-Han-Nal) / 液體茶 / 100ML /瓶核定编码: 30049069009日期: 2018
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者Hiruscar Silicone Pro(non-sterile) 喜療疤 疤痕護理矽凝膠(未滅菌)核定编码: 30049099904日期: 2018
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者貽貝粘蛋白創面修復敷料 型號、規格:0.5mg/mL×0.2mL、0.5mg/mL×0.5mL、0.5mg/mL×1mL、0.5mg/mL×3mL、0.5mg/mL×5mL 0.5mg/mL×10mL、0.5mg/mL×15mL、0.5mg/mL×20mL、1.5mg/mL×0.2mL、1.5mg/mL×0.5mL 1.5mg/mL×3mL、……、1.5mg/mL×20mL等(詳附件)核定编码: 30049099904日期: 2018
- 其他中藥製劑云南彝葯排毒眼罩核定编码: 30049069009日期: 2018
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者恢甲清覆甲筆(未滅菌) EXCILOR Nail Pen(non-sterile)核定编码: 30049099904日期: 2017
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者恢甲清覆甲液(未滅菌) EXCILOR Nail Solution(non-sterile)核定编码: 30049099904日期: 2017
- 其他中藥製劑黃金紅蔘精/液體(茶)食品/Net wt. 250g/真空玻璃瓶核定编码: 30049069009日期: 2017
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者品名:通用名:骨修復材料 商標名:骨優導 / 型號規格:1mg rhBMP-2/Bottle核定编码: 30049099904日期: 2017
- 其他中藥製劑韓國護肝寶 HD-1 Premium核定编码: 30049069009日期: 2017
- 其他中藥製劑晋山之韵/台灣商品名:沛之臨 益甘飲核定编码: 30049069009日期: 2017
- 其他中藥製劑慶珍丸核定编码: 30049069009日期: 2016
- 其他中藥製劑紅蔘鹿茸元氣精核定编码: 30049069009日期: 2016
- 其他中藥製劑五加皮精核定编码: 30049069009日期: 2016
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者ESOXX ONE核定编码: 30049099904日期: 2016
显示其他国家的案例 (30)
- KRㅇ 재우스오라쿠고에이취플라스타(살리실산); OLAKUKO - H;
- KRMedicaments; 재우스오라쿠고에이취플라스타(살리실산)
- KRPOSS
- KRS1
- KRBOSS
- KRMedicaments; DIABEX XR 500mg
- KRINVISIBLE MASK
- KRMedicaments, packings for retail sale
- KRMedicament; Mentho Pas Lotion
- KRMedicaments, anti-cancer preparation TEPADINA, Thiotepa
- KRMedicaments; 인애백년보건고; PR.CHNA
- KRMedicaments; FD; MEXICO
- KRMedicaments; Turbocaina; MEXICO
- KRMedicaments; Nutriband Slimline patch; U.S.A
- KRCollagen Preparation; COLTRIX CartiRegen
- USThe tariff classification of Pantoprazole Sodium Tablets in dosage form, from India
- USThe tariff classification of Tadalafil Tablets in dosage form, from India
- USThe tariff classification of Nintedanib Capsules in dosage form, from India
- USThe tariff classification of Brivaracetam Oral Solution in dosage form, from India
- USThe tariff classification of Colestipol Hydrochloride Tablets in dosage form, from Taiwan
来源: 台湾财政部 — 海外网购虽容易 频繁进口要留意 · 台湾关务署 — 海关如何课征进口货物营业税 · 台湾关务署 — 进口货物应缴之税费有哪些 · 台湾关务署 — 大陆物品准许输入项目为何 · 台湾台北关 — 进口快递货物简易申报应注意及配合事项 · 台湾财政部法规系统 — 空运快递货物简易申报通关作业规定 · 台湾国际贸易署 — 大陆物品输入特别规定查询 · 台湾食品药物管理署 — 化妆品产品登录专区 · Census Bureau: Foreign Trade Regulations frequently asked questions · eCFR: 15 CFR part 30, Foreign Trade Regulations · CBP: Automated Export System (AES) · International Trade Administration: Electronic Export Information (EEI) · Bureau of Industry and Security: Export Administration Regulations · Census Bureau: Schedule B search engine
身份: 个人/小卖家 — 会改变页面强调的板块